News/Articles
Have you always wanted to get cosmetic surgery but either couldn't afford it or were afraid of undergoing a cosmetic procedure? A new facelift takes the fear out of cosmetic surgery with a nonsurgical facelift that's extremely safe, minimally invasive, convenient and affordable, delivering radiant, natural-looking results. What more could you ask for?
Berkshire Information Systems, Inc., (Berkshire) a leading provider of e-commerce fulfillment solutions through e2e-store, announced the launch of their newest e-commerce site with Pharmaco LLC. Pharmaco LLC is the supplier of Invisible Veins, a vascular support product and dietary supplement.
HarmonyXL could be the answer to the prayers of consumers who seek less invasive skin rejuvenation. The multi-functional device's antiaging secret is its combination of light- and laser-based treatment approaches, which targets a variety of skin concerns and types with less post-treatment recovery time. The skin treatment innovation is now available to patients of Manhattan's Juva Skin and Laser Center.
SAN JOSE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for
the minimally invasive treatment of venous reflux disease, today announced its
plans to present at the UBS Global Life Sciences Conference, to be held
September 22-25, 2008, at the Grand Hyatt Hotel in New York City.
SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- BioForm Medical, Inc.
(Nasdaq: BFRM) today announced that the pivotal clinical study of Polidocanol,
conducted in Germany by BioForm Medical's partner, Chemische Fabrik KREUSSLER
& Co. GmbH (Kreussler), successfully met the study primary endpoint and has
been submitted to FDA as part of a New Drug Application (NDA) process.
SAN FRANCISCO, Sept. 1 /PRNewswire/ -- As baby boomers age, varicose veins
can signal health concerns of not merely unsightly veins, but sometimes
painful ulcers that can be a harbinger of a potential for stroke. Fortunately,
a fairly simple procedure of laser surgery exists that can reduce the risk of
serious complications.
Cynosure designates Soluna MD as an official trainer and clinical reference center for Smartlipo. So, why go anywhere else for physician training or to attain this revolutionary, minimally invasive procedure that offers superior body sculpting and
skin-tightening results?
SHAANXI, China, July 29 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-
Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading
developer and producer of plant extracts and raw materials used in the
production of pharmaceuticals, nutraceuticals and food production, today
released an investor update on the status of its application for COS approval
for the delivery of Diosmin to Safic-Alcan.
CHICAGO, July 29 /PRNewswire/ -- Varicose veins -- unsightly bulging veins
in the legs -- force many embarrassed sufferers to cover up, even on the
hottest summer days. While often dismissed as a cosmetic issue, varicose veins
actually can develop into serious health problems. According to a new survey,
many who suffer from varicose veins aren't aware of this and are not seeking
treatment for their condition. The survey, sponsored by Vein Clinics of
America, found that one in five people reported having varicose veins, and
half (48 percent) also experienced aching pain in the legs. Surprisingly,
most people (87 percent) reported they have never sought treatment and nearly
half (42 percent) do not consider varicose veins to be a serious health issue.
SAN JOSE, Calif., July 28 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for
the minimally invasive treatment of venous reflux disease, today announced its
plans to present at the BMO Capital Markets 2008 Focus on Healthcare
Conference, to be held August 5-6, 2008, at the Millennium Broadway Hotel in
New York City.
A minimally invasive treatment for a common cause of male infertility can significantly improve a couple's chances for pregnancy, according to a new study published in the August issue of Radiology.
SAN JOSE, Calif., July 14 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for
the minimally invasive treatment of peripheral vascular disease, announced
today that it plans to report its financial results for the second quarter
ended June 30, 2008, after the close of market on July 29.
SAN JOSE, Calif., July 11 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for
the minimally invasive treatment of venous reflux disease, announced today the
resignation of Kathleen D. LaPorte from the Board of Directors. Ms. LaPorte
has served on VNUS' Board of Directors since April 1997 and was a general
partner in a venture capital firm that funded the company during its start-up
activities. There are no immediate plans for a replacement Director.
SAN JOSE, Calif., July 2 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for
the minimally invasive treatment of venous reflux disease, announced today
that it has asserted patent infringement claims in the United States District
Court, Northern District of California, against biolitec Inc. (Biolitec),
Dornier MedTech America, Inc. (Dornier) and NewStar Lasers, Inc. d/b/a
CoolTouch, Inc. (CoolTouch).
ATLANTA, June 26 /PRNewswire/ -- Rarely written about, seldom spoken of,
and often times left untreated, vein disease negatively affects the lives of
an astonishing 40% of women and 25% of men. Bulging, knotted, twisted varicose
veins take over legs and turn what once were ordinary tasks and activities
into painful ordeals.
Non-Payment Plan Aims to Reduce Preventable Hospital Acquired Infections & Medical Errors
SAN JOSE, Calif., June 16 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for
the minimally invasive treatment of venous reflux disease, today announced its
plans to present at the William Blair & Company 28th Annual Growth Stock
Conference, to be held June 17-19, 2008, at the Four Seasons Hotel in Chicago,
IL.
SAN JOSE, Calif., June 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS) updates and corrects its estimate of royalty
revenues for 2008. Royalty revenues in 2008 are estimated to be $12.5 to
$12.9 million which is changed from the previously announced royalty revenues
of $11.3 to $11.7 million.
SAN JOSE, Calif., June 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS) today announced that it has entered into an
Agreement with AngioDynamics (Nasdaq: ANGO) and Vascular Solutions
(Nasdaq: VASC) that settles and resolves the patent infringement lawsuit
between the companies filed in 2005. The Agreement results in VNUS granting
to AngioDynamics and Vascular Solutions, a non-exclusive, non-sublicensable
patent license that covers certain products such as disposable endovenous
laser fiber kits, laser fibers, and lasers used in the field of endovenous
laser ablation.
LAS VEGAS, May 29 /PRNewswire/ -- Alma Lasers Ltd. ("Alma Lasers"), a
global developer and marketer of laser, light, and radiofrequency based
aesthetic devices, announced today at THE Aesthetic Show 2008 FDA clearance
for its Harmony(XL), the newest platform for multiple aesthetic laser and
light treatments. The Harmony(XL) can be used to treat more than 60 popular
aesthetic indications and applications, including acne, skin rejuvenation,
hair removal, varicose veins, stretch marks, tattoo removal, wrinkles and skin
tightening.